RxDoctor Payments Data

Alli Delp, DO

Family Medicine · Norton, VANPI 1992155303

Payments from drug & device makers

$750in general payments, 2019–2025

Across 42 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$109
  • Amarin Pharma, Inc.$94
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$78
  • Novartis$71
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$65
  • AbbVie$65
  • plus $267 from 9 others

What the payments were for

  • Food & beverage$750100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$750 in reported general payments places this provider in the 65th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$29,531
Medicare patients
90
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$115,403
EliquisApixaban103$78,980
JardianceEmpagliflozin52$57,007
JanuviaSitagliptin Phosphate47$54,988
FarxigaDapagliflozin Propanediol55$48,780
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$46,976
MounjaroTirzepatide25$40,525
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$22,547
VraylarCariprazine Hcl11$17,176
LinzessLinaclotide18$16,073
TrulicityDulaglutide17$15,844
SymbicortBudesonide/Formoterol Fumarate39$13,899
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$11,588
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$8,134
MyrbetriqMirabegron14$6,469

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$109$115,40388 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$40$74,267110 claims
Boehringer IngelheimJardiance$37$57,00752 claims
AbbVieVraylar, Linzess$65$33,24929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Norton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →